BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Basta F, Möckel T, Petersohn J, Meineck M, Triantafyllias K, Engel S, Weinmann A, Luessi F, Weinmann-Menke J, Schwarting A. The relationship between BAFF serum levels, anti-NMDAR autoantibodies and fatigue in patients with systemic lupus erythematosus and multiple sclerosis. Autoimmun Rev 2021;20:102802. [PMID: 33727153 DOI: 10.1016/j.autrev.2021.102802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang Y, Sun J, Wei J. Distinct binding mode of BAFF antagonist antibodies belimumab and tabalumab, analyzed by computer simulation. J Mol Model 2022;28:292. [PMID: 36063219 DOI: 10.1007/s00894-022-05142-7] [Reference Citation Analysis]
2 Samões B, Zen M, Abelha-Aleixo J, Gatto M, Doria A. Caveats and pitfalls in defining low disease activity in systemic lupus erythematosus. Autoimmun Rev 2022;21:103165. [PMID: 35931316 DOI: 10.1016/j.autrev.2022.103165] [Reference Citation Analysis]
3 Mubariki R, Vadasz Z. The role of B cell metabolism in autoimmune diseases. Autoimmun Rev 2022;:103116. [PMID: 35595053 DOI: 10.1016/j.autrev.2022.103116] [Reference Citation Analysis]
4 Flessa CM, Zampeli E, Evangelopoulos ME, Natsis V, Bodewes ILA, Huijser E, Versnel MA, Moutsopoulos HM, Mavragani CP. Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren's Syndrome. Front Immunol 2022;13:836824. [PMID: 35371038 DOI: 10.3389/fimmu.2022.836824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]